Introduction This scoping review includes studies on pharmaceutical access, shortages,
generics, availability, pharmacoeconomics, and pricing restrictions. The study's findings may …

Purpose Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death in
the Saudi Arabia (KSA). Over the last decade dyslipidemia has been the predominant risk …

Abstract Background Saudi Arabia's Vision 2030 aims to reform health care across the
Kingdom, with health technology assessment being adopted as one tool promising to …

Saudi Arabia is undergoing a massive healthcare transformation to fulfill its new, national
“Vision 2030.” To align with this objective, Saudi Arabia is establishing a new, independent …

In this paper we outline and compare pharmaceutical pricing policies for in-patent
prescription pharmaceuticals with emphasis on external reference pricing (ERP) in eleven …

Background: Pharmaceutical costs are the fastest-growing healthcare expense in most
countries, meaning that physicians are required to adopt cost-conscious behavior in their …

Objective The recent establishment of the health technology assessment (HTA) entity in the
Kingdom of Saudi Arabia (KSA) has resulted in increased interest in economic evaluation …

Objectives Capacity building exercises are important to increase understanding of
healthcare processes by key stakeholders, and to facilitate open discussions to build …

Background The number of published economic evaluations of Gulf Cooperation Council
(GCC) countries is notably scarce. Limited local evidence could have a major impact on the …

Background Healthcare payers are increasingly adopting managed entry agreements
(MEAs) between themselves and manufacturers, to overcome the challenge of sustaining …